T. Rowe Price Associates’s Rubius Therapeutics, Inc RUBY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-70,400	Closed	-$31K	–	3018
2022 Q3	$31K	Hold	70,400	–	–	﹤0.01%	2885
2022 Q2	$60K	Sell	70,400 -914,246	-93%	-$779K	﹤0.01%	2831
2022 Q1	$5.43M	Buy	984,646 +54,467	+6%	+$300K	﹤0.01%	1452
2021 Q4	$9M	Buy	+930,179	New	+$9M	﹤0.01%	1418